Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use

Transient Elastography–Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United States

(2021) Aynur Unalp-Arida et al.   Clinical Gastroenterology and Hepatology

Transient Elastography Accurately Screens for Compensated Advanced Chronic Liver Disease in Patients With Ongoing or Recent Alcohol Withdrawal

(2021) Ludivine Legros et al.   Clinical Gastroenterology and Hepatology

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

(2020) Yasaman Vali et al.   JOURNAL OF HEPATOLOGY

Virtual Touch Quantification using Acoustic Radiation Force Impulse Imaging Technology versus Transient Elastography for the Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C using Liver Biopsy as the Gold Standard

(2020) Victor Bâldea et al.   Journal of Gastrointestinal and Liver Diseases

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease

(2020) Arjun N.A. Jayaswal et al.   LIVER INTERNATIONAL

Alcohol-related liver disease: Time for action

(2019) Ramon Bataller et al.   JOURNAL OF HEPATOLOGY

Non-invasive diagnosis and biomarkers in alcohol-related liver disease

(2019) Christophe Moreno et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma in the setting of alcohol-related liver disease

(2019) Nathalie Ganne-Carrié et al.   JOURNAL OF HEPATOLOGY

Inflammatory pathways in alcoholic steatohepatitis

(2019) Bin Gao et al.   JOURNAL OF HEPATOLOGY

Evaluation of Safety and Effectiveness of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Switch Followed by Ledipasvir/Sofosbuvir HCV Therapy in HIV–HCV Coinfection

(2019) Mary-Anne Doyle et al.   Open Forum Infectious Diseases

Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia

(2019) Miquel Serra-Burriel et al.   JOURNAL OF HEPATOLOGY

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

(2019) Marc G. Ghany et al.   HEPATOLOGY

Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?

(2018) Arantza Sanvisens et al.   DRUG AND ALCOHOL DEPENDENCE

Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder

(2018) Daniel Fuster et al.   DRUG AND ALCOHOL DEPENDENCE

Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia

(2018) Natalia Gnatienko et al.   HIV CLINICAL TRIALS

The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study

(2018) Maryam Alavi et al.   JOURNAL OF HEPATOLOGY

Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification

(2018) Maja Thiele et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease

(2018) Mark Thursz et al.   JOURNAL OF HEPATOLOGY

Comparative study between four ultrasound Shear Waves Elastographic methods for liver fibrosis assessment

(2018) Ioan Sporea et al.   Medical Ultrasonography

Liquid biopsy for liver diseases

(2018) Jelena Mann et al.   GUT

Alcohol Use in Patients with Chronic Liver Disease

(2018) Daniel Fuster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease

(2018) Jorge-Luis Torres et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Hepatitis C infection substantially reduces survival of alcohol-dependent patients

(2018) Roberto Muga et al.   Clinical Epidemiology

Alcoholic liver disease

(2018) Helmut K. Seitz et al.   Nature Reviews Disease Primers

American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases

(2017) Siddharth Singh et al.   GASTROENTEROLOGY

Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review

(2017) Veeral H. Ajmera et al.   HEPATOLOGY

FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients

(2017) Kaku A. So-Armah et al.   HEPATOLOGY

Detecting liver fat from viscoelasticity: How good is CAP in clinical practice? The need for universal cut-offs

(2017) Manuel Romero-Gómez et al.   JOURNAL OF HEPATOLOGY

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

(2017) Thomas Karlas et al.   JOURNAL OF HEPATOLOGY

Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients

(2017) Marcelo Soto et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Prospective Evaluation of Liver Stiffness Using Transient Elastography in Alcoholic Patients Following Abstinence

(2016) Elena Gianni et al.   ALCOHOL AND ALCOHOLISM

Systematic review with meta-analysis: diagnostic accuracy of transient elastography for staging of fibrosis in people with alcoholic liver disease

(2016) C. S. Pavlov et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis

(2016) Maja Thiele et al.   GASTROENTEROLOGY

Virtual Touch™ Quantification to Diagnose and Monitor Liver Fibrosis in Hepatitis B and Hepatitis C: A NICE Medical Technology Guidance

(2016) Jennifer A. Summers et al.   Applied Health Economics and Health Policy

Causes of Death in People with Liver Cirrhosis in England Compared with the General Population: A Population-Based Cohort Study

(2015) Sonia Ratib et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease

(2015) Michael Fernandez et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease

(2015) Sebastian Mueller et al.   LIVER INTERNATIONAL

Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus–Infected, and Uninfected Patients

(2014) Joseph K. Lim et al.   CLINICAL INFECTIOUS DISEASES

High Levels of Alcohol Consumption Increase the Risk of Advanced Hepatic Fibrosis in HIV/Hepatitis C Virus-Coinfected Patients: A Sex-Based Analysis Using Transient Elastography at Enrollment in the HEPAVIH ANRS CO13 Cohort

(2014) F. Marcellin et al.   CLINICAL INFECTIOUS DISEASES

Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease

(2014) Sylvie Naveau et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients

(2014) D. Fuster et al.   JOURNAL OF VIRAL HEPATITIS

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

(2014) Roger Williams et al.   LANCET

Prevalence of Hepatitis C Virus Infection in Alcoholic Patients: Cohort Study and Systematic Review

(2013) Ignacio Novo-Veleiro et al.   ALCOHOL AND ALCOHOLISM

Impact of Lifetime Alcohol Use on Liver Fibrosis in a Population of HIV-Infected Patients With and Without Hepatitis C Coinfection

(2013) Daniel Fuster et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Liver fibrosis progression in HIV–HCV-coinfected patients treated with distinct antiretroviral drugs and impact of peginterferon-ribavirin therapy

(2013) José V Fernández-Montero et al.   ANTIVIRAL THERAPY

Évaluation pronostique de la maladie alcoolique du foie : comment et pourquoi ?

(2013) Jean-Baptiste Trabut et al.   PRESSE MEDICALE

Does an Index Composed of Clinical Data Reflect Effects of Inflammation, Coagulation, and Monocyte Activation on Mortality Among Those Aging With HIV?

(2012) A. C. Justice et al.   CLINICAL INFECTIOUS DISEASES

Estimated Liver Fibrosis and its Impact on All-Cause Mortality of HCV-Monoinfected and HCV/HIV-Coinfected Drug Users

(2012) A. Sanvisens et al.   CURRENT HIV RESEARCH

Unhealthy Alcohol Use, HIV Infection and Risk of Liver Fibrosis in Drug Users with Hepatitis C

(2012) Roberto Muga et al.   PLoS One

Delayed Diagnosis of HCC with Chronic Alcoholic Liver Disease

(2012) Kerstin Schütte et al.   Liver Cancer

Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis

(2011) Kiran Bambha et al.   AIDS

HIV Mono-infection Is Associated With FIB-4 - A Noninvasive Index of Liver Fibrosis - in Women

(2011) J. T. Blackard et al.   CLINICAL INFECTIOUS DISEASES

Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard

(2011) Thierry Poynard et al.   JOURNAL OF HEPATOLOGY

Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection

(2010) David Nunes et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States

(2010) Jessica A. Davila et al.   HEPATOLOGY

Can Transient Elastography Replace Liver Histology for Determination of Advanced Fibrosis in Alcoholic Patients

(2010) Filip Janssens et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

A position statement on NAFLD/NASH based on the EASL 2009 special conference

(2010) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Increased liver stiffness in alcoholic liver disease: Differentiating fibrosis from steatohepatitis

(2010) Sebastian Mueller   WORLD JOURNAL OF GASTROENTEROLOGY

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY

Alcoholic liver disease

(2009) Robert S. O'Shea et al.   HEPATOLOGY

Primary Care Validation of a Single-Question Alcohol Screening Test

(2009) Peter C. Smith et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

(2009) Nina F. Schwenzer et al.   JOURNAL OF HEPATOLOGY

Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with 1H magnetic resonance spectroscopy

(2009) Marcello Mancini et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Validation and Comparison of Simple Noninvasive Indexes for Predicting Liver Fibrosis in HIV-HCV-Coinfected Patients: ANRS CO3 Aquitaine Cohort

(2008) Marc-Arthur Loko et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

(2008) Sylvie Naveau et al.   HEPATOLOGY

Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort

(2008) AA Chaudhry et al.   HIV MEDICINE

Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease

(2008) Pierre Nahon et al.   JOURNAL OF HEPATOLOGY